Improvement in CNS protective treatment in non-high-risk childhood acute lymphoblastic leukemia: Report from the Japanese Children's Cancer and Leukemia Study Group

Medical and Pediatric Oncology

Volumn 32, Issue 4, 1999, Pages 259-266

  Tsurusawa, Masahito ^a   Katano, Naoyuki ^a   Yamamoto, Yoshifumi ^a   Hirota, Takahisa ^a   Koizumi, Syoichi ^a   Watanabe, Arata ^a   Takeda, Takeo ^a   Hatae, Yosirou ^a   Yatabe, Michio ^a   Mimaya, Junichi ^a   Gushiken, Toshiki ^a   Nishi, Kunihiro ^a   Anami, Kenichi ^a   Kikuta, Atsushi ^a   Kanegane, Hirokazu ^a   Asami, Keiko ^a   Nishikawa, Kenichi ^a   Sekine, Isao ^a   Kawano, Yoshifumi ^a   Iwai, Asayuki ^a   Furuyama, Teruhisa ^a   Ijichi, Osamu ^a   Miyake, Munenori ^a   Mugishima, Hideo ^a   Ota, Shigeru ^a   Fujimoto, Takeo ^a   more..

^a AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia in childhood; CNS prophylactic therapy

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; MERCAPTOPURINE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN PROTECTION; CANCER COMBINATION CHEMOTHERAPY; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CHILDHOOD CANCER; DOSE RESPONSE; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; SKULL IRRADIATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT; INJECTIONS, SPINAL; JAPAN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 13044267744     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199904)32:4<259::AID-MPO4>3.0.CO;2-3     Document Type: Article

References (25)

1. Steinherz PG. Radiotherapy vs. intrathecal chemotherapy for CNS prophylaxis in childhood ALL. Oncology 1989;3:47-53.
2. Packer RJ, Meadows AT, Rorke LB, et al. Long-term sequel of cancer treatment on the central nervous system in childhood. Med Pediatr Oncol 1987;15:241-253.
3. Otis JJ. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol 1989;11:93-105.
4. Smibert E, Anderson V, Godbet T, et al. Risk factors for intellectual and educational sequel of cranial irradiation in childhood acute lymphoblastic leukemia. Br J Cancer 1996;73:825-830.
5. Bleyer WA, Sather HN, Nickerson HJ, et al. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the children's cancer study group. J Clin Oncol 1991;9:1012-1021.
6. Tubergen DG, Gilchrist GS, O'Brien RT, et al. Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and importance of systemic therapy - a children's cancer group report. J Clin Oncol 1993;11:520-526.
7. Sullivan MP, Chen T, Dyment PG, et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood 1982;60:948-958.
8. Krance RA, Newman EM, Ravindranath Y, et al. A pilot study of intermediate-dose methotrexate and cytosine arabinoside, "spread-out" or "up-front," in continuation therapy for childhood non-T, non-B acute lymphoblastic leukemia. Cancer 1991; 67:550-556.
9. Pullen J, Boyett J, Shuster J, et al. Extended triple intrathecal chemotherapy trial for prevention of CNS relapse in good-risk and poor-risk patients with B- progenitor acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol 1993;11:839-849.
10. Pui CH, Simone JV, Hancock ML, et al. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St. Jude total therapy X. Leukemia 1992;6:150-157.
11. Rivera GK, Raimondi SC, Hancock ML, et al. Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337:61-66.
12. Buhrer C, Henze G, Hofmann J, et al. Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials. Hematol Blood Transfus 1990;33:500-503.
13. Reiter A, Schrappe M, Ludwig WF, et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients: results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994;84:3122-3133.
14. Conter V, Arico M, Valsecchi MG, et al. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. J Clin Oncol 1995;13:2497-2502.
15. Steinherz PG, Gaynon P, Miller DR, et al. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen-a new intensive therapy protocol: a report from the childrens cancer study group. J Clin Oncol 1986;4:744-752.
16. Van Eys J, Berry D, Crist W, et al. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood: a Pediatric Oncology Group study. Cancer 1989;63:23-29.
17. Cherlow JM, Steinherz PG, Sather HN, et al. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the children's cancer group. Int J Radiation Oncology Biol Phys 1993;27:1001-1009.
18. Gelber RD, Sallan ES, Cohen HJ, et al. Central nervous system treatment in childhood acute lymphoblastic leukemia: long-term follow up of patients diagnosed between 1973 and 1985. Cancer 1993;72:261-270.
19. Hiyoshi Y, Fujimoto T, Kuriya N, et al. Prognostic factors in children with acute lymphoblastic leukemia. II. Multivariate analysis. Jpn J Clin Oncol 1985;15:13-23.
20. Koizumi S, Fujimoto T. Improvement in treatment of childhood acute lymphoblastic leukemia: a 10-year study by the children's cancer and leukemia study group. Int J Hematol 1994;59:99-112.
21. Koizumi S, Fujimoto T, Oka T, et al. Overview of clinical studies of childhood acute lymphoblastic leukemia for more than ten years by the Japanese children's cancer and leukemia study group. Pediat Hematol Oncol 1997;14:17-28.
22. Gelman R, Gelber R, Henderson C, et al. Improved methodology for analyzing local and distant recurrence. J Clin Oncol 1990;8-548-555.
23. Kramar A, Arriagada R. Analyzing local and distant recurrence. J Clin Oncol 1990;8:2086-2087.
24. Arriagada R, Kramar A, Le Chevalier T, et al. Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol 1992;10:447-451.
25. 2 methotrexate. Leuk Lymphoma 1994;12:141-144.